Nautilus Biotechnology, Inc.
NAUT- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001808805
No open-market purchases or sales by Nautilus Biotechnology, Inc. insiders were filed in the last 90 days; 93 institutions reported holding it in 13F filings for Q2 2026, worth $93.7M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Nautilus Biotechnology, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 73 | 75 | +2 |
| Shares | 44.5M | 44.8M | +304.3K (+0.7%) |
| Value | $123.3M | $173.4M | +$50.2M (+40.7%) |
New holders (9)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MetLife Investment Management | 28,043 | $108.5K | 0.00% |
| Alliancebernstein L.P. | 15,840 | $61.3K | 0.00% |
| State Board of Administration of Florida Retirement System | 14,330 | $55.5K | 0.00% |
| PDS Planning, Inc | 10,455 | $40.5K | 0.01% |
| Price T Rowe Associates Inc | 10,012 | $39.0K | 0.00% |
| Citadel Advisors LLC | 4,742 | $18.4K | 0.00% |
| Metropolitan Life Insurance Co | 3,129 | $12.1K | 0.00% |
| Financial Synergies Wealth Advisors, Inc. | 291 | $1.13K | 0.00% |
| Covestor Ltd | 5 | $0 | 0.00% |
Sold out (7)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Group One Trading, L.P. | 149,748 | $414.8K |
| Simplex Trading, LLC | 61,113 | $169.0K |
| Wolverine Trading, LLC | 32,326 | $85.0K |
| SG Americas Securities, LLC | 20,810 | $58.0K |
| Prelude Capital Management, LLC | 13,944 | $38.6K |
| Belvedere Trading LLC | 8,985 | $24.9K |
| EverSource Wealth Advisors, LLC | 633 | $1.75K |